Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Susok

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Acta Dermato-Venereologica|February 28, 2014
Interstitial granulomatous dermatitis associated with myelodysplastic syndrome - complete clearance under therapy with 5-azacytidineNikolaos Patsinakidis, Laura Susok, Schapoor Hessam, et al.
Cancers|November 13, 2021
Waiving Subsequent Complete Lymph Node Dissection in Melanoma Patients with Positive Sentinel Lymph Node Does Not Result in Worse Outcome on 20-Year AnalysisLaura Susok, Celine Nick, Jürgen C Becker, et al.
Dermatology and Therapy|April 13, 2021
Comparison of the Skin Cancer Quality of Life Impact Tool and the Skin Cancer Index Questionnaire in Measurement of Health-Related Quality of Life and the Effect of Patient Education Brochures in Patients with Actinic Keratosis, Non-melanoma Skin Cancer, and Cutaneous MelanomaSam El Abbadi, Laura Susok, Egger Stockfleth, et al.
Dermatology and Therapy|May 7, 2021
Correction to: Comparison of the Skin Cancer Quality of Life Impact Tool and the Skin Cancer Index Questionnaire in Measurement of Health-Related Quality of Life and the Effect of Patient Education Brochures in Patients with Actinic Keratosis, Non-melanoma Skin Cancer, and Cutaneous MelanomaSam El Abbadi, Laura Susok, Egger Stockfleth, et al.
Frontiers in Medicine|October 9, 2025
A phase 2b basket trial approach to treat multiple rare and fibrotic skin diseasesSebastian Volc, Peter Martus, Matthias Schefzyk, et al.
Cancers|September 23, 2022
Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma PatientsThilo Gambichler, Andreas Stang, Rita Mansour, et al.
Vaccines|May 25, 2024
Current Progress in Vaccines against Merkel Cell Carcinoma: A Narrative Review and UpdateThilo Gambichler, David Schrama, Riina Käpynen, et al.
Clinical and Experimental Dermatology|May 12, 2023
A 21-year-old woman with progressive asymptomatic skin laxity in flexural regionsThilo Gambichler, Sabine Hoffjan, Mato Nagel, et al.
Journal of Cancer Research and Clinical Oncology|June 8, 2024
High-dose chemotherapy and autologous hematopoietic stem cell transplantation for progressive systemic sclerosis: a retrospective study of outcome and prognostic factorsVanessa Pyka, Deepak B Vangala, Thomas Mika, et al.
Cancers|March 13, 2025
Low Intratumoral CD200 Protein Expression in Primary Merkel Cell Carcinoma Is a Strong Predictor for Disease RelapseThilo Gambichler, Sophia Girke, Nessr Abu Rached, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Acta Dermato-Venereologica|February 28, 2014
Interstitial granulomatous dermatitis associated with myelodysplastic syndrome - complete clearance under therapy with 5-azacytidineNikolaos Patsinakidis, Laura Susok, Schapoor Hessam, et al.
Cancers|November 13, 2021
Waiving Subsequent Complete Lymph Node Dissection in Melanoma Patients with Positive Sentinel Lymph Node Does Not Result in Worse Outcome on 20-Year AnalysisLaura Susok, Celine Nick, Jürgen C Becker, et al.
Dermatology and Therapy|April 13, 2021
Comparison of the Skin Cancer Quality of Life Impact Tool and the Skin Cancer Index Questionnaire in Measurement of Health-Related Quality of Life and the Effect of Patient Education Brochures in Patients with Actinic Keratosis, Non-melanoma Skin Cancer, and Cutaneous MelanomaSam El Abbadi, Laura Susok, Egger Stockfleth, et al.
Dermatology and Therapy|May 7, 2021
Correction to: Comparison of the Skin Cancer Quality of Life Impact Tool and the Skin Cancer Index Questionnaire in Measurement of Health-Related Quality of Life and the Effect of Patient Education Brochures in Patients with Actinic Keratosis, Non-melanoma Skin Cancer, and Cutaneous MelanomaSam El Abbadi, Laura Susok, Egger Stockfleth, et al.
Frontiers in Medicine|October 9, 2025
A phase 2b basket trial approach to treat multiple rare and fibrotic skin diseasesSebastian Volc, Peter Martus, Matthias Schefzyk, et al.
Cancers|September 23, 2022
Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma PatientsThilo Gambichler, Andreas Stang, Rita Mansour, et al.
Vaccines|May 25, 2024
Current Progress in Vaccines against Merkel Cell Carcinoma: A Narrative Review and UpdateThilo Gambichler, David Schrama, Riina Käpynen, et al.
Clinical and Experimental Dermatology|May 12, 2023
A 21-year-old woman with progressive asymptomatic skin laxity in flexural regionsThilo Gambichler, Sabine Hoffjan, Mato Nagel, et al.
Journal of Cancer Research and Clinical Oncology|June 8, 2024
High-dose chemotherapy and autologous hematopoietic stem cell transplantation for progressive systemic sclerosis: a retrospective study of outcome and prognostic factorsVanessa Pyka, Deepak B Vangala, Thomas Mika, et al.
Cancers|March 13, 2025
Low Intratumoral CD200 Protein Expression in Primary Merkel Cell Carcinoma Is a Strong Predictor for Disease RelapseThilo Gambichler, Sophia Girke, Nessr Abu Rached, et al.
Pageof 10